论文部分内容阅读
基础免疫学家、动物实验者和临床医生于年初共同分析了细胞免疫用于癌症治疗的研究状况,探讨了进一步评价和利用癌细胞免疫反应所存在的关键问题。显然,免疫物质可使癌肿缩小,其中对T细胞反应的特异性给人类癌症治疗带来很大希望。以往认为癌症为免疫学所做的贡献比免疫学对癌症的贡献要大,近年来免疫学的发展已改变了这种观念。关于T细胞对抗原提呈,识别、激活、生长、转运和与内皮细胞反应的新见解,提示了肿瘤抗原是如何被免疫系统所识
At the beginning of this year, basic immunologists, animal experimenters and clinicians jointly analyzed the research status of cellular immunity in the treatment of cancer and discussed the key problems in further evaluation and utilization of cancer cell immune responses. Obviously, the immune substance can make the cancer shrink, and the specificity of the response to the T cell brings great hope for the treatment of human cancer. In the past, the contribution of cancer to immunology was thought to be greater than the contribution of immunology to cancer. The development of immunology in recent years has changed this notion. New insights into the presentation, recognition, activation, growth, transport, and response of T cells to the antigen suggest how the tumor antigen is recognized by the immune system